| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,118,000 | 3,270,000 | 3,192,000 | 3,102,000 | | Cost of Revenue |
-
| 1,408,000 | 1,426,000 | 1,364,000 | | | Gross Profit | 3,118,000 | 1,862,000 | 1,766,000 | 1,738,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,227,000 | 59,000 | 46,000 | 45,000 | | Non Recurring | 217,000 | 323,000 | 1,000 | 6,000 | | Others | 355,000 | 396,000 | 336,000 | 337,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,319,000 | 1,084,000 | 1,383,000 | 1,350,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,000 | 48,000 | (5,000) | 7,000 | | Earnings Before Interest And Taxes | 1,326,000 | 1,132,000 | 1,378,000 | 1,357,000 | | Interest Expense | 136,000 | 121,000 | 100,000 | 111,000 | | Income Before Tax | 1,190,000 | 1,011,000 | 1,278,000 | 1,246,000 | | Income Tax Expense | 251,000 | 210,000 | 175,000 | 140,000 | | Minority Interest |
-
| (1,000) | 3,000 | 1,000 | | | | Net Income From Continuing Ops | 939,000 | 800,000 | 1,106,000 | 1,107,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 939,000 | 800,000 | 1,106,000 | 1,107,000 | | Preferred Stock And Other Adjustments | 3,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $942,000 | $800,000 | $1,106,000 | $1,107,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
